넥스젤(NXGL)는 NASDAQ에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $0.27 (+2.63%), 시가총액 $0.00B, 52주 최저~최고 $0.57 ~ $2.78.
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the conve
넥스젤의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
넥스젤의 현재 주가는 $0.27 (+2.63%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
넥스젤의 시가총액은 약 $0.00B입니다.
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics